Addition of Lactobacillus to Metronidazole in Treatment of CDAD
Status:
Withdrawn
Trial end date:
2010-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether dietary supplementation with Lactobacillus
GG will reduce the rate of failure or relapse following treatment of CDAD with metronidazole.
Phase:
Phase 4
Details
Lead Sponsor:
Michael E. DeBakey VA Medical Center VA Medical Center, Houston